Closed · RFA-FD-15-002 · CFDA 93.103 · Discretionary
Fostering Cooperation and Strengthening Medical Product Regulatory Systems in the Americas
Federal grant opportunity posted by Food and Drug Administration, cataloged on Grants.gov.
- $2M-$10M
- Award range
- Closed
- Status
- August 9, 2014
- Close date
- 1
- Expected awards
The verdict
Fostering Cooperation and Strengthening Medical Product Regulatory Systems in the Americas is a closed discretionary listing from Food and Drug Administration that offered $2,000,000 -- $10,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 481 other opportunities from Food and Drug Administration.
- $2M-$10M
- award range
- Closed
- application status
- 1
- expected award
- 93.103
- CFDA program
Archived opportunity record
Fostering Cooperation and Strengthening Medic… is closed (last close August 9, 2014). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed August 9, 2014
Est. Total Funding
$10,000,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
The Food and Drug Administration (FDA) is announcing its intent to accept a single source application for RFA-FD-15-002 to award a Cooperative Agreement to the Pan American Health Organization. The goal of the funding is to foster regulatory cooperation and strengthen regional regulatory systems in the Americas through activities that may include:Developing and applying regional/global norms and standards in the Americas for medical product regulation;research involving generating and analyzing evidence on regulatory systems gaps and opportunities; their performance; and emerging challenges and trends that may impact system performance; and,providing technical support to regulatory systems strengthening efforts: including, developing strategies to expand the knowledge about the criticality of regulatory systems within the broader global health context.Research ObjectivesThe Cooperative Agreement would represent the further expansion of well-established collaborations between OIP/FDA and PAHO in support of data-driven and science-based public health strategies and approaches. The objective is to build upon existing cooperation to foster regulatory collaboration and strengthen regulatory capacity throughout the Americas in ways that provide benefit and contribution to the FDA regulatory and public health mission. This partnership aligns with FDA's domestic and global goals of addressing medical product safety and quality challenges.This Cooperative Agreement would support collaboration and investigation in the following areas: Developing and applying regional/global norms and standards• Enable the sharing of scientific findings and data through expert meetings and technical consultations; • Assist Member States in the implementation and subsequent evaluation of internationally-recognized standards and guidelines, e.g. WHO guidelines and standards and those emerging from standards development venues such as the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH);• Utilize PAHO’s convening power to engage with relevant stakeholders on science-based norms and standards;• Facilitate the alignment and convergence of standards between PAHO, other regions, and/or global bodies.Generating and analyzing evidence of regulatory systems performance• Contribute to the knowledge base of the current state of medical product regulation globally, including challenges, risks, and emerging trends, and making the business case for investments in regulatory systems;• Enable and/or further strengthen the development of data/information systems as sources of inputs for evidence-based regulatory decisions and actions and enhanced knowledge management systems, coalitions, and networks;Providing technical support to regulatory systems strengthening efforts and expanding awareness of the role of regulatory systems in the broader global health development framework • Enable the strengthening of regulatory systems at the regional and global levels in such critical domains as: regulatory frameworks; marketing authorization; import/export control and postmarket surveillance; inspections; laboratories; pharmacovigilance; clinical trials; and vaccine lot release; staff development and training, including the professionalization of the regulatory workforce; monitoring and evaluation of product quality; inspection and surveillance of products throughout the supply chain; risk assessment, analysis, and management. • Contribute strategies to expand the knowledge and awareness of the essential role of regulatory systems within the broader global health and development frameworks, including ways that can leverage existing initiatives, investments and partnerships or catalyze new ones.
Catch-all / unrestricted eligibility mark · RFA-FD-15-002
Grants.gov marks Fostering Cooperation and Strengthening Medic… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Regional Development (RD). 119 other Food and Drug Administration listings share this eligibility-code string (25% of 482).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Food and Drug Administration Research
U.S. Department of Health and Human Services
Agency Contact
Oluyemisi Akinneye Grants Management Specialist Phone 240-402-7560
More from Food and Drug Administration
Federal and University Partnership to Improve the Safety of Seafood from the Gulf of America
Research, Education, and Outreach on Botanical Natural Products
Cooperative Agreement to Support Shellfish Safety Assistance Project
Education and Outreach to Tribal Producers through the Tribal Food Safety Alliance
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
What to do next
Fostering Cooperation and Strengthening Medic… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.103 may publish future NOFOs under the same assistance listing. Open program
- Food and Drug Administration Research indexes 42 Grants.gov listings in this extract. Program profile
- Food and Drug Administration lists 481 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |